Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.
Trimble, E L, Adams, J D, Vena, D, Hawkins, M J, Friedman, M A, Fisherman, J S, Christian, M C, Canetta, R, Onetto, N, Hayn, RVolume:
11
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.1993.11.12.2405
Date:
December, 1993
File:
PDF, 539 KB
1993